======= NFYB =======
== Gene Information ==
* **Official Symbol**: NFYB
* **Official Name**: nuclear transcription factor Y subunit beta
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=4801|4801]]
* **UniProt**: [[https://www.uniprot.org/uniprot/P25208|P25208]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=NFYB&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20NFYB|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/189904|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: N/A
* **UniProt Summary**: Component of the sequence-specific heterotrimeric transcription factor (NF-Y) which specifically recognizes a 5'- CCAAT-3' box motif found in the promoters of its target genes. NF- Y can function as both an activator and a repressor, depending on its interacting cofactors.
|Histone|
|CBFD NFYB HMF|
|CCAAT-binding factor complex|
|repressing transcription factor binding|
|regulation of sterol biosynthetic process|
|regulation of cholesterol biosynthetic process|
|protein-DNA complex|
|regulation of cholesterol metabolic process|
|RNA polymerase II transcription factor complex|
|regulation of alcohol biosynthetic process|
|regulation of steroid biosynthetic process|
|cellular response to leukemia inhibitory factor|
|response to leukemia inhibitory factor|
|RNA polymerase II distal enhancer sequence-specific DNA binding|
|regulation of steroid metabolic process|
|regulation of lipid biosynthetic process|
|transcription regulatory region DNA binding|
|protein-containing complex binding|
|regulation of lipid metabolic process|
|regulation of small molecule metabolic process|
|protein heterodimerization activity|
|DNA-binding transcription factor activity|
|cellular response to cytokine stimulus|
|response to cytokine|
|DNA binding|
|positive regulation of transcription, DNA-templated|
|DNA-binding transcription factor activity, RNA polymerase II-specific|
|positive regulation of nucleic acid-templated transcription|
|positive regulation of RNA biosynthetic process|
|positive regulation of RNA metabolic process|
|positive regulation of nucleobase-containing compound metabolic process|
|positive regulation of macromolecule biosynthetic process|
|positive regulation of cellular biosynthetic process|
|positive regulation of gene expression|
|positive regulation of biosynthetic process|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp1|5-Fluorouracil 2μM R00 exp1]]|1.7|
|[[:results:exp6|Bortezomib 0.005μM R00 exp6]]|1.75|
|[[:results:exp457|Bisphenol F 50μM R08 exp457]]|1.87|
|[[:results:exp27|Pimelic-diphenylamide-106 0.5μM R00 exp27]]|2.02|
|[[:results:exp416|Tubacin 1.6μM R07 exp416]]|2.47|
|[[:results:exp25|Oligomycin-A 2μM R00 exp25]]|2.58|
^Gene^Correlation^
|[[:human genes:n:nfyc|NFYC]]|0.452|
|[[:human genes:c:cox8a|COX8A]]|0.412|
Global Fraction of Cell Lines Where Essential: 129/726
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|1/1|
|909776.0|0/1|
|bile duct|5/28|
|blood|6/28|
|bone|6/25|
|breast|8/33|
|central nervous system|12/56|
|cervix|0/4|
|colorectal|1/17|
|esophagus|1/13|
|fibroblast|0/1|
|gastric|1/15|
|kidney|2/21|
|liver|3/20|
|lung|15/75|
|lymphocyte|4/14|
|ovary|6/26|
|pancreas|2/24|
|peripheral nervous system|3/16|
|plasma cell|3/15|
|prostate|0/1|
|skin|7/24|
|soft tissue|0/7|
|thyroid|0/2|
|upper aerodigestive|2/22|
|urinary tract|3/29|
|uterus|1/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 1548
* **Expression level (log2 read counts)**: 5.17
{{:chemogenomics:nalm6 dist.png?nolink |}}